Events2Join

Aclaris Therapeutics Acquires Confluence Life Sciences


Aclaris Therapeutics Acquires Confluence Life Sciences, Inc.

Aclaris Therapeutics, Inc. (Aclaris) (NASDAQ:ACRS), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing ...

Aclaris Therapeutics Acquires Confluence Life Sciences, Inc.

(“Aclaris”) (NASDAQ:ACRS), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and ...

CONFLUENCE LIFE SCIENCES ACQUISITION - Aclaris Therapeutics

© Copyright 2017 Aclaris Therapeutics. All rights reserved. A-1. Dr. Neal Walker. President and CEO. August 2017. CONFLUENCE LIFE SCIENCES. ACQUISITION. Page 2 ...

BioGenerator-Backed Confluence Life Sciences Achieves ... - BioSTL

Confluence Life Sciences, Inc. has been acquired by Aclaris Therapeutics, Inc. (NASDAQ: ACRS) for the St. Louis company's world-class research team.

Epidarex Capital Portfolio Company, Confluence Life Sciences ...

Epidarex Capital Portfolio Company, Confluence Life Sciences, Acquired by Aclaris Therapeutics ... August 10, 2017 – Epidarex Capital (“Epidarex”), an early stage ...

Aclaris Therapeutics Buys Confluence Life Sciences in $100 Million ...

St. Louis-based Confluence generated profits through contract-research subsidiary ... Biotechnology startup Confluence Life Sciences Inc. didn't ...

Aclaris Acquires Confluence in $10M Deal - ProQuest

... therapies to address significant unmet needs in medical and aesthetic dermatology, announced that it has acquired Confluence Life Sciences, Inc., a ...

Aclaris-buys-kinase-focused-Confluence - C&EN

Confluence Life Sciences, a St. Louis-based developer of kinase inhibitors for cancer and other diseases, has been acquired by Aclaris Therapeutics for $10 ...

Confluence Life Sciences - News & Media - BioGenerator Ventures

Confluence was acquired by Aclaris Therapeutics (Nasdaq: ACRS), providing returns to investors; As Aclaris Therapeutics, the Confluence drug candidates ...

How Confluence Acquisition Will Work For Aclaris In St. Louis | EQ

Yesterday, BioGenerator's first co-working lab tenant, Confluence Life Sciences, got acquired by Aclaris Therapeutics, Inc at a valuation of $100MM.

A Wholly Owned Subsidiary of Aclaris Therapeutics, Inc.

Confluence Life Sciences, Inc. by Aclaris Therapeutics, Inc. As ... changed as a result of the acquisition of Confluence Discovery Technologies, ...

Pepper Hamilton Represents Aclaris Therapeutics During ...

Aclaris, a Malvern-based dermatologist-led biopharmaceutical company, recently announced that it has acquired Confluence Life Sciences, ...

aacrs_Ex21 - SEC.gov

AGREEMENT AND PLAN OF MERGER. by and among. ACLARIS THERAPEUTICS, inc.,. ACLARIS life sciences, INC.,. confluence life sciences, inc. and,. SOLELY IN ITS ...

Aclaris Acquires Confluence Life Sciences - YouTube

Aclaris Acquires Confluence Life Sciences a St. Louis R & D Company -Visit our website: http://stltv.net - Like us on Facebook: ...

Confluence's $100 million acquisition is a win for St. Louis' biotech ...

Yesterday, BioGenerator's first co-working lab tenant, Confluence Life Sciences, got acquired by Aclaris Therapeutics, Inc. at a valuation ...

Aclaris Therapeutics (ACRS) Acquires Confluence Life Sciences for ...

Aclaris Therapeutics (ACRS) Acquires Confluence Life Sciences for $10M Cash, 350K Shares. August 8, 2017 7:13 AM. Aclaris Therapeutics, Inc. (“Aclaris ...

Aclaris Therapeutics acquires Confluence Life Sciences - Crunchbase

Aclaris Therapeutics acquires Confluence Life Sciences on 2017-08-08 for $100000000.

BioGenerator-Backed Confluence Life Sciences Achieves ... - BioSTL

Confluence Life Sciences, Inc. has been acquired by Aclaris Therapeutics, Inc. (NASDAQ: ACRS) for the St. Louis company's world-class ...

St. Louis startup Confluence Life Sciences sold to Philadelphia's ...

Louis bioscience company founded by former Pfizer researchers, is being acquired by Aclaris Therapeutics Inc. in a deal worth up to $100 million ...

Aclaris Therapeutics acquires Confluence Life Sciences - | BioWorld

Aclaris Therapeutics has acquired Confluence Life Sciences, a company focused on the discovery and development of kinase inhibitors to treat ...